ÂÜÀòÂÒÂ×

Reid Huber, PhD, is currently a Partner at Third Rock Ventures and focuses on discovering, launching, and building innovative, value-creating, product engine-focused companies across multiple therapeutic areas. Previously, Dr Huber was at Incyte Corporation, most recently serving as the company’s Executive Vice President and Chief Scientific Officer, where he led drug discovery research primarily in the area of hematology/oncology. Prior to joining Incyte, Dr Huber held scientific research positions at DuPont Pharmaceuticals and Bristol-Myers Squibb from 1997 to 2002. Dr Huber received his PhD in molecular genetics from the Washington University School of Medicine and held pre- and post-doctoral fellowships at the National Institutes of Health.